Lifevantage Corporation (LFVN) To Go Ex-Dividend on September 1st

Lifevantage Corporation (NASDAQ:LFVN) announced a quarterly dividend on Thursday, August 20th. Investors of record on Tuesday, September 1st will be paid a dividend of 0.05 per share on Tuesday, September 15th. This represents a c) dividend on an annualized basis and a yield of 3.1%. The ex-dividend date of this dividend is Tuesday, September 1st.

Lifevantage has a dividend payout ratio of 18.5% indicating that its dividend is sufficiently covered by earnings.

Lifevantage Trading Down 1.4%

Shares of NASDAQ:LFVN opened at $6.36 on Friday. Lifevantage has a 1-year low of $3.90 and a 1-year high of $14.28. The stock has a market capitalization of $80.26 million, a P/E ratio of 15.90 and a beta of 0.72. The business has a 50-day moving average price of $6.42 and a two-hundred day moving average price of $5.84.

Lifevantage (NASDAQ:LFVN) last issued its earnings results on Thursday, August 27th. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.01). The business had revenue of $42.38 million during the quarter, compared to the consensus estimate of $44.00 million. Lifevantage had a net margin of 2.78% and a return on equity of 21.63%. As a group, equities analysts predict that Lifevantage will post 0.65 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on LFVN. Lake Street Capital raised their price objective on shares of Lifevantage from $5.00 to $6.00 and gave the company a “hold” rating in a research note on Friday. Weiss Ratings reissued a “hold (c)” rating on shares of Lifevantage in a research note on Friday, August 21st. Two research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $5.50.

Lifevantage Company Profile

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.